Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
432.15
-8.95 (-2.03%)
Jun 2, 2025, 3:30 PM IST
NSE:INDRAMEDCO Revenue
In the fiscal year ending March 31, 2025, Indraprastha Medical Corporation had annual revenue of 13.56B INR with 8.97% growth. Indraprastha Medical Corporation had revenue of 3.34B in the quarter ending March 31, 2025, with 6.04% growth.
Revenue
13.56B
Revenue Growth
+8.97%
P/S Ratio
2.92
Revenue / Employee
4.56M
Employees
2,977
Market Cap
39.62B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 13.56B | 1.12B | 8.97% |
Mar 31, 2024 | 12.45B | 1.46B | 13.29% |
Mar 31, 2023 | 10.99B | 2.11B | 23.70% |
Mar 31, 2022 | 8.88B | 2.75B | 44.80% |
Mar 31, 2021 | 6.13B | -2.17B | -26.17% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 271.45B |
Mankind Pharma | 122.07B |
Apollo Hospitals Enterprise | 217.94B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Alkem Laboratories | 129.65B |